For the first time, the U.S. Food and Drug Administration (FDA) has approved the use of a ketamine-like drug as a stand-alone therapy for adults with treatment-resistant depression (TRD).

ketamine seems to block glutamate. That's why it's such an effective anesthetic. But in low doses, like what you might find at a club or in a spray of the FDA-approved drug esketamine, it actually ...

Mental health providers in Central Illinois offering ketamine say it has changed patients' lives for the better. Still, only ...

A watershed moment came in March when the U.S. Food and Drug Administration (FDA) approved Spravato, or esketamine, a ketamine nasal spray for adults with treatment-resistant major depression.

“Esketamine is a form of ketamine, a drug that was first used as a sedating or anesthetic agent in horses,” Fargason said. “Ketamine has also been used for decades as a brief surgical anesthetic in ...

We published the book "Demystifying Psychiatry" in 2010. Although basic principles of psychiatric treatment remain unchanged, ...

The inferior molecule of ketamine — SPRAVTO or esketamine, which Johnoson & Johnson patents — has been FDA-approved for TRD. SPRAVTO is a nasal spray administered to patients. Still, it does not have ...

We specialize in ketamine and esketamine (Spravato, a form of ketamine) for depression, anxiety, PTSD, and OCD here in Sacramento. Ketamine is a cutting-edge, evidence-based treatment backed by ...

This is because the Food and Drug Administration (FDA) only approves the drug ketamine for use in general anesthetics. However, Medicare may cover the drug Spravato, which contains esketamine.

Limitless provides immersive guided visualizations that help patients feel safe and anchored while leveraging the neuroplasticity created by ketamine. For patients undergoing Spravato (esketamine ...

The goal of the track is to provide additional, specialized clinical training and scholarship experiences in interventional psychiatry modalities such as electroconvulsive therapy (ECT), transcranial ...